Lemonade Return Rate
Rate Of Return$Hims & Hers Health(HIMS.US)
There's still a 200EMA overhead. If it can officially break through and clean up the resistance above, it's not far from a real rally.
Today's announcement that it can sell Eli Lilly's products means the company has officially abandoned the compound drug of GLP-1. Compliance is the only right path for a pharmaceutical company. Looking back at the recent garbage time was still quite agonizing. Let's see if there are any related follow-up news; I'm quite interested in their recent wave of important decisions.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
